| # | Drug | Count |
|---|---|---|
| 0 | ETONOGESTREL | 11 |
| 1 | ISOTRETINOIN | 6 |
| 2 | LEVONORGESTREL | 5 |
| 3 | CERTOLIZUMAB PEGOL | 3 |
| 4 | COPPER | 3 |
| 5 | ETONOGESTREL AND ETHINYL ESTRADIOL | 3 |
| 6 | GLATIRAMER ACETATE | 3 |
| 7 | ARIPIPRAZOLE | 2 |
| 8 | ESCITALOPRAM | 2 |
| 9 | LEVOTHYROXINE SODIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GANIRELIX ACETATE | 1 | 0.0013 |
| 1 | MENOTROPINS | 1 | 0.0005 |
| 2 | MIFEPRISTONE | 1 | 0.0002 |
| 3 | ETONOGESTREL | 11 | 0.0002 |
| 4 | SAPROPTERIN DIHYDROCHLORIDE | 1 | 0.0002 |
| 5 | ETONOGESTREL AND ETHINYL ESTRADIOL | 3 | 0.0001 |
| 6 | ISOTRETINOIN | 6 | 0.0001 |
| 7 | AGALSIDASE BETA | 1 | 0.0001 |
| 8 | MISOPROSTOL | 1 | 0.0001 |
| 9 | METHADONE HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 19 |
| 1 | Retinoid [EPC] | 6 |
| 2 | Progestin-containing Intrauterine System [EPC] | 5 |
| 3 | Atypical Antipsychotic [EPC] | 4 |
| 4 | Estrogen [EPC] | 4 |
| 5 | Copper-containing Intrauterine Device [EPC] | 3 |
| 6 | Benzodiazepine [EPC] | 2 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 2 |
| 8 | Proton Pump Inhibitor [EPC] | 2 |
| 9 | Anti-IgE [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gonadotropin [EPC] | 1 | 0.0005 |
| 1 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Progestin [EPC] | 19 | 0.0001 |
| 4 | Copper-containing Intrauterine Device [EPC] | 3 | 0.0001 |
| 5 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 6 | Progesterone [EPC] | 1 | 0.0000 |
| 7 | Retinoid [EPC] | 6 | 0.0000 |
| 8 | Estrogen [EPC] | 4 | 0.0000 |
| 9 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |